Why the study?
Does treatment with ACE inhibitors or ARBs reduce tumor growth and lymphangiogenesis in a nude mouse model of gastric cancer?
Does treatment with ACE inhibitors or ARBs reduce tumor growth and lymphangiogenesis in a nude mouse model of gastric cancer?
In a mouse model of gastric cancer, ACE inhibitors and ARBs significantly inhibited tumor growth and lymphangiogenesis.
No takes yet. Share an insight, caveat, or question.
Findings limited to murine models; leaves open any therapeutic role for ACEI/ARBs in human gastric cancer.
Wang et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: